ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

EuroIntervention

Volumn 10, Issue 4, 2014, Pages 466-474

  Lønborg, Jacob ^a   Kelbæk, Henning ^a   Engstrøm, Thomas ^a   Helqvist, Steffen ^a   Kløvgaard, Lene ^a   Holmvang, Lene ^a   Vejlstrup, Niels ^a   Jørgensen, Erik ^a   Saunamäki, Kari ^a   Dridi, Nadia P ^a   Kaltoft, Anne ^b   Bøtker, Hans Erik ^b   Clemmensen, Peter ^a   Terkelsen, Christian Juhl ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Primary percutaneous coronary intervention; Reperfusion injury; ST peak; ST segment elevation myocardial infarction; ST segment resolution

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EXENDIN 4; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PLACEBO;

ADJUVANT THERAPY; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CORONARY STENTING; CORRELATION ANALYSIS; ELECTROCARDIOGRAPHY MONITORING; EPICARDIUM; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC POSTCONDITIONING; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURVIVAL RATE; AGED; EARLY DIAGNOSIS; HEART; HEART MUSCLE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; EARLY DIAGNOSIS; FEMALE; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 84930713749     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I4A80     Document Type: Article

References (34)

1. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schomig A, Kastrati A. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55:2383-9.
2. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, Shimada K, Yoshikawa J. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002;105:2148-52.
3. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97:2302-6.
4. Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, Pache J, Seyfarth M, Schomig A, Kastrati A. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;52:512-7.
5. Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107:2115-9.
6. Brodie BR, Stuckey TD, Hansen C, VerSteeg DS, Muncy DB, Moore S, Gupta N, Downey WE. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;95:343-8.
7. Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation. 2008;118:1335-46.
8. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 1999;99:1972-7.
9. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, Novikov I, Di Segni E, Agranat O, Har-Zahav Y, Rabinowitz B, Kaplinsky E, Hod H. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol. 1999;34:1932-8.
10. McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:1215-23.
11. Ndrepepa G, Alger P, Kufner S, Mehilli J, Schomig A, Kastrati A. ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Cardiol J. 2012;19:61-9.
12. Sejersten M, Valeur N, Grande P, Nielsen TT, Clemmensen P. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2). J Am Coll Cardiol. 2009;54:1763-9.
13. van 't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet. 1997;350:615-9.
14. Figueras J, Cortadellas J. Further elevation of the ST segment during the first hour of thrombolysis. A possible early marker of reperfusion. Eur Heart J. 1995;16:1807-13.
15. Nilsson JB, Jensen S, Ottander P, Naslund U. The electrocardiographic reperfusion peak in patients with ST-elevation myocardial infarction. Scand Cardiovasc J. 2007;41:25-31.
16. Shechter M, Rabinowitz B, Beker B, Motro M, Barbash G, Kaplinsky E, Hod H. Additional ST segment elevation during the first hour of thrombolytic therapy: an electrocardiographic sign predicting a favorable clinical outcome. J Am Coll Cardiol. 1992;20:1460-4.
17. Wehrens XH, Doevendans PA, Ophuis TJ, Wellens HJ. A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J. 2000;139:430-6.
18. Feldman LJ, Himbert D, Juliard JM, Karrillon GJ, Benamer H, Aubry P, Boudvillain O, Seknadji P, Faraggi M, Steg G. Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size. J Am Coll Cardiol. 2000;35:1162-9.
19. Kobayashi N, Ohmura N, Nakada I, Yasu T, Iwanaka H, Kubo N, Katsuki T, Fujii M, Yaginuma T, Saito M. Further ST elevation at reperfusion by direct percutaneous transluminal coronary angioplasty predicts poor recovery of left ventricular systolic function in anterior wall AMI. Am J Cardiol. 1997;79:862-6.
20. Lønborg J, Kelbæk H, Holmvang L, Vejlstrup N, Jørgensen E, Helqvist S, Saunamaki K, Dridi NP, Ahtarovski KA, Terkelsen CJ, Bøtker HE, Kim WY, Treiman M, Clemmensen P, Engstrøm T. ST peak during primary percutaneous coronary intervention predicts final infarct size, left ventricular function, and clinical outcome. J Electrocardiol. 2012;45:708-16.
21. Miida T, Oda H, Toeda T, Higuma N. Additional ST-segment elevation immediately after reperfusion and its effect on myocardial salvage in anterior wall acute myocardial infarction. Am J Cardiol. 1994;73:851-5.
22. Nilsson JB, Eriksson A, Naslund U. Transient Increase in ST-segment Changes at Time of Reperfusion in Acute Myocardial Infarction Treated by Coronary Angioplasty. J Invasive Cardiol. 1998;10:246-50.
23. Ochiai M, Isshiki T, Takeshita S, Oshima A, Toyoizumi H, Kondo K, Sato T, Miyashita H. Relation of duration of ST reel-evation at reperfusion and improvement of left ventricular function after successful primary angioplasty of the left anterior descending coronary artery in anterior wall acute myocardial infarction. Am J Cardiol. 1997;79:1667-70.
24. Terkelsen CJ, Kaltoft AK, Norgaard BL, Bottcher M, Lassen JF, Clausen K, Nielsen SS, Thuesen L, Nielsen TT, Botker HE, Andersen HR. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction. J Electrocardiol. 2009;42:64-72.
25. Terkelsen CJ, Norgaard BL, Lassen JF, Poulsen SH, Gerdes JC, Sloth E, Gotzsche LB, Romer FK, Thuesen L, Nielsen TT, Andersen HR. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study). Eur Heart J. 2006;27:267-75.
26. Nijveldt R, van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, van Rossum AC, Zijlstra F. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging. 2009;2:1187-94.
27. Kelbæk H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Bøtker HE, Saunamaki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Thuesen L. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51:899-905.
28. Lønborg J, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrøm T. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv. 2010;3:34-41.
29. Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2012;33:1491-9.
30. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-13.
31. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.
32. Lev EI, Kornowski R, Vaknin-Assa H, Brosh D, Fuchs S, Battler A, Assali A. Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2008;101:435-9.
33. Armstrong PW, Siha H, Fu Y, Westerhout CM, Steg PG, James SK, Storey RF, Horrow J, Katus H, Clemmensen P, Harrington RA, Wallentin L. ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy. Circulation. 2012;125:514-21.
34. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol. 2008;52: 181-9.